Horizon Therapeutics Public Ltd Co

Swedbank AB

Report date

9/30/2023

Quarter

2023 Q3

Filed

12/6/2024

Shares

776,494

Value ($000)

89,833

Weight

0.2%

2021 Q1 - 2023 Q3 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	12/6/2024	89,833	0.2%	776,494	9/30/2023
2023 Q2	12/6/2024	79,626	0.1%	774,194	6/30/2023
2023 Q1	12/6/2024	119,082	0.2%	1,091,094	3/31/2023
2022 Q4	12/6/2024	126,124	0.3%	1,108,294	12/31/2022
2022 Q3	12/6/2024	93,057	0.2%	1,503,594	9/30/2022
2022 Q2	12/6/2024	95,145	0.2%	1,192,894	6/30/2022
2022 Q1	12/6/2024	69,280	0.1%	658,494	3/31/2022
2021 Q4	12/6/2024	69,135	0.1%	638,600	12/31/2021
2021 Q3	12/6/2024	69,952	0.1%	638,600	9/30/2021
2021 Q2	12/6/2024	59,799	0.1%	638,600	6/30/2021
2021 Q1	12/6/2024	56,872	0.1%	617,900	3/31/2021